TASKEEN MIDGETTE: Open Payments
NPI 1730886029 · NEW BERN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,599 in 80 payments from 21 companies in 2025. Trend: 2023 $1,506 · 2024 $1,618 · 2025 $1,599
Food & beverage: $1,510Education: $89
| Company | Payments | Amount |
|---|---|---|
| SCPHARMACEUTICALS INC. | 8 | $226 |
| E.R. Squibb & Sons, L.L.C. | 21 | $208 |
| BridgeBio Pharma, Inc. | 4 | $184 |
| Actelion Pharmaceuticals US, Inc. | 7 | $177 |
| Merck Sharp & Dohme LLC | 9 | $142 |
| Novo Nordisk Inc | 6 | $123 |
| Providence Medical Technology, Inc. | 1 | $87 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $75 |
| Alnylam Pharmaceuticals Inc. | 4 | $73 |
| Baxter Healthcare | 1 | $54 |
Products named: FUROSCIX, Attruby, CAMZYOS, OPSUMIT, Wegovy, VERQUVO, ELIQUIS, JARDIANCE.
Industry payments across NC — which companies pay providers there.
